We systematically analyzed the distribution of HER2 amplification and clinicopathological features across various subtypes of cervical adenocarcinomas using IECC, a new pathogenetic classification for invasive endocervical adenocarcinoma [5]. Here, ERBB2 is linked to endocervical adenocarcinoma.